| Literature DB >> 33499194 |
Oana-Mihaela Plotogea1,2, Madalina Ilie1,2, Simona Bungau3, Alexandru Laurentiu Chiotoroiu4, Ana Maria Alexandra Stanescu5, Camelia Cristina Diaconu1,6.
Abstract
The impact of sleep disorders (SDs) on patients with chronic liver diseases (CLD) is tremendous. SDs are frequently encountered among these patients and interfere with their quality of life. This review aims to present the data available so far about the prevalence, phenotypes, and proposed pathophysiological mechanisms of SDs in CLD. Moreover, we proposed to search the literature regarding the most reliable methods to assess SDs and the possible therapeutic options in patients with CLD. The main results of this review show that when it comes to prevalence, the percentages reported vary widely between studies performed among populations from the USA or Europe and those coming from Asian countries. Furthermore, it has been proven that SDs may also be present in the absence of neurocognitive disorders attributable to hepatic encephalopathy (HE), which contradicts traditional suppositions where SDs were considered part of the clinical scenario of HE. Currently, there are no specific recommendations or protocols to assess SDs in CLD patients and data about the therapeutic management are limited. Taking into consideration their impact, a protocol for diagnosing and managing SDs should be developed and included in the daily practice of hepatologists.Entities:
Keywords: actigraphy; cirrhosis; hepatic encephalopathy; melatonin; questionnaires; sleep disorders; therapies
Year: 2021 PMID: 33499194 PMCID: PMC7911845 DOI: 10.3390/brainsci11020142
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425